Zoledronic Acid Injection
Product Images NDC 72266-152

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 72266-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fosun Pharma Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Label (Bag Label)

Label for Zoledronic Acid Injection 5 mg per 100 mL sterile solution for intravenous infusion. The label specifies not to mix with calcium-containing solutions and emphasizes infusion time of at least 15 minutes. Distributed by Fosun Pharma USA Inc. The package contains a single 100 mL bag, made in India, marked Rx only.*

FDA Label Image

Image01 (Image01)

Chemical structure of zoledronic acid, showing its molecular framework with phosphonate groups and an imidazole ring.*

FDA Label Image

Image02 (Image02)

A line graph comparing time to first hip fracture (months) for Zoledronic acid injection 5 mg/100 mL versus placebo. The graph shows cumulative incidence over 36 months, with separate lines for Zoledronic acid and placebo, indicating a difference in fracture occurrence.*

FDA Label Image

Image03 (Image03)

Two bar graphs comparing Zoledronic acid and Risedronate over time. The first graph shows therapeutic response rates by day (10 to 182). Zoledronic acid has higher response rates at each time point. The second graph shows serum alkaline phosphatase (SAP) normalization percentages over days 28 to 182, with Zoledronic acid showing greater SAP normalization than Risedronate. Both graphs include statistical significance markers (P < 0.001).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.